Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Agilent Technologies plans to at least double its oligonucleotide manufacturing capacity with an expansion of its plant in Frederick, Colo. The project is expected to create between 150 and 200 jobs. The instrumentation firm began its foray into nucleic acids in 2006 with the acquisition of SynPro. In 2008, it purchased Dow Chemical’s oligonucleotides business and moved it from Michigan to Colorado.
This article has been sent to the following recipient: